百利天恒股价下跌2.54% 定增募资37.64亿获批

Group 1 - The core stock price of Baili Tianheng as of August 7, 2025, is 298.41 yuan, with a decrease of 7.78 yuan, representing a decline of 2.54% [1] - The trading volume on the same day was 7278 hands, with a total transaction amount of 220 million yuan [1] - Baili Tianheng focuses on innovative drug research and development, with its main business covering chemical drug formulations and traditional Chinese medicine research, production, and sales [1] Group 2 - On the evening of August 7, Baili Tianheng announced that its application for the issuance of stocks to specific targets has been approved by the China Securities Regulatory Commission [1] - The total amount of funds to be raised in this issuance is not expected to exceed 3.764 billion yuan, which will be entirely used for innovative drug research and development projects [1] - The net outflow of main funds for Baili Tianheng on that day was 1.6973 million yuan, with a cumulative net outflow of 4.6502 million yuan over the past five days [1]